View in EDS PDF Full Text

Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.

Saved in:
Bibliographic Details
Title: Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.
Authors: Zhang X; Rubius Therapeutics, Inc., Cambridge, MA, USA., Luo M; Rubius Therapeutics, Inc., Cambridge, MA, USA., Dastagir SR; Rubius Therapeutics, Inc., Cambridge, MA, USA., Nixon M; Rubius Therapeutics, Inc., Cambridge, MA, USA., Khamhoung A; Rubius Therapeutics, Inc., Cambridge, MA, USA., Schmidt A; Rubius Therapeutics, Inc., Cambridge, MA, USA., Lee A; Rubius Therapeutics, Inc., Cambridge, MA, USA., Subbiah N; Rubius Therapeutics, Inc., Cambridge, MA, USA., McLaughlin DC; Rubius Therapeutics, Inc., Cambridge, MA, USA., Moore CL; Rubius Therapeutics, Inc., Cambridge, MA, USA., Gribble M; Rubius Therapeutics, Inc., Cambridge, MA, USA., Bayhi N; Rubius Therapeutics, Inc., Cambridge, MA, USA., Amin V; Rubius Therapeutics, Inc., Cambridge, MA, USA., Pepi R; Rubius Therapeutics, Inc., Cambridge, MA, USA., Pawar S; Rubius Therapeutics, Inc., Cambridge, MA, USA., Lyford TJ; Rubius Therapeutics, Inc., Cambridge, MA, USA., Soman V; Rubius Therapeutics, Inc., Cambridge, MA, USA., Mellen J; Rubius Therapeutics, Inc., Cambridge, MA, USA., Carpenter CL; Rubius Therapeutics, Inc., Cambridge, MA, USA., Turka LA; Rubius Therapeutics, Inc., Cambridge, MA, USA., Wickham TJ; Rubius Therapeutics, Inc., Cambridge, MA, USA., Chen TF; Rubius Therapeutics, Inc., Cambridge, MA, USA. tiffany.chen@rubiustx.com.
Source: Nature communications [Nat Commun] 2021 May 11; Vol. 12 (1), pp. 2637. Date of Electronic Publication: 2021 May 11.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Video-Audio Media
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33976146
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Luo+M%22">Luo M</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dastagir+SR%22">Dastagir SR</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nixon+M%22">Nixon M</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Khamhoung+A%22">Khamhoung A</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schmidt+A%22">Schmidt A</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+A%22">Lee A</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+N%22">Subbiah N</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22McLaughlin+DC%22">McLaughlin DC</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moore+CL%22">Moore CL</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gribble+M%22">Gribble M</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bayhi+N%22">Bayhi N</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Amin+V%22">Amin V</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pepi+R%22">Pepi R</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pawar+S%22">Pawar S</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lyford+TJ%22">Lyford TJ</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Soman+V%22">Soman V</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mellen+J%22">Mellen J</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Carpenter+CL%22">Carpenter CL</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Turka+LA%22">Turka LA</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wickham+TJ%22">Wickham TJ</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+TF%22">Chen TF</searchLink>; Rubius Therapeutics, Inc., Cambridge, MA, USA. tiffany.chen@rubiustx.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 May 11; Vol. 12 (1), pp. 2637. <i>Date of Electronic Publication: </i>2021 May 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Video-Audio Media
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33976146
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-021-22898-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2637
    Titles:
      – TitleFull: Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Luo M
      – PersonEntity:
          Name:
            NameFull: Dastagir SR
      – PersonEntity:
          Name:
            NameFull: Nixon M
      – PersonEntity:
          Name:
            NameFull: Khamhoung A
      – PersonEntity:
          Name:
            NameFull: Schmidt A
      – PersonEntity:
          Name:
            NameFull: Lee A
      – PersonEntity:
          Name:
            NameFull: Subbiah N
      – PersonEntity:
          Name:
            NameFull: McLaughlin DC
      – PersonEntity:
          Name:
            NameFull: Moore CL
      – PersonEntity:
          Name:
            NameFull: Gribble M
      – PersonEntity:
          Name:
            NameFull: Bayhi N
      – PersonEntity:
          Name:
            NameFull: Amin V
      – PersonEntity:
          Name:
            NameFull: Pepi R
      – PersonEntity:
          Name:
            NameFull: Pawar S
      – PersonEntity:
          Name:
            NameFull: Lyford TJ
      – PersonEntity:
          Name:
            NameFull: Soman V
      – PersonEntity:
          Name:
            NameFull: Mellen J
      – PersonEntity:
          Name:
            NameFull: Carpenter CL
      – PersonEntity:
          Name:
            NameFull: Turka LA
      – PersonEntity:
          Name:
            NameFull: Wickham TJ
      – PersonEntity:
          Name:
            NameFull: Chen TF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 05
              Text: 2021 May 11
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1